Health
Subset of COVID-19 patients have increased bleeding risk – EurekAlert
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
The human body strives to keep itself in homeostasis, or balance. When blood clots are created, the body’s innate response is to break the clots down to prevent significant health problems from arising.
Research has found that patients with COVID-19 are prone to serious blood clotting. This is why many patients receive high dose anticoagulants as part of their treatment.
But a new study in Scientific Reports, led by senior author Daniel Lawrence, Ph.D., a Professor of Basic Research in Cardiovascular…
-
Noosa News23 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News24 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General22 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
Noosa News20 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane